Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 23.85
+1.35 (6.00%)
Aug 12, 2025, 1:44 PM CST
Silk Road Medical Revenue
In the year 2024, Locus Cell had annual revenue of 2.36M TWD with 480.30% growth. Locus Cell had revenue of 861.00K in the quarter ending December 31, 2024, with 112.07% growth.
Revenue
2.36M
Revenue Growth
+480.30%
P/S Ratio
1,910.02
Revenue / Employee
44.45K
Employees
53
Market Cap
4.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.36M | 1.95M | 480.30% |
| Dec 31, 2023 | 406.00K | -194.00K | -32.33% |
| Dec 31, 2022 | 600.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 3,401.20B |
| Hon Hai Precision Industry | 7,179.94B |
| MediaTek | 573.54B |
| Delta Electronics | 469.36B |
| Fubon Financial Holding | 814.41B |
| Quanta Computer | 1,637.49B |
| Chunghwa Telecom | 233.45B |
| Cathay Financial Holding | 842.91B |